Roivant Sciences Ltd (NASDAQ: ROIV) on Tuesday, soared 1.38% from the previous trading day, before settling in for the closing price of $19.6. Within the past 52 weeks, ROIV’s price has moved between $8.73 and $20.08.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -99.51%. The company achieved an average annual earnings per share of -430.71%. With a float of $415.35 million, this company’s outstanding shares have now reached $682.23 million.
Roivant Sciences Ltd (ROIV) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Roivant Sciences Ltd is 39.18%, while institutional ownership is 64.06%. The most recent insider transaction that took place on Oct 15 ’25, was worth 7,020,583. In this transaction President & Immunovant CEO of this company sold 414,683 shares at a rate of $16.93, taking the stock ownership to the 1,504,959 shares. Before that another transaction happened on Oct 16 ’25, when Company’s President & Immunovant CEO sold 318,282 for $17.05, making the entire transaction worth $5,426,708. This insider now owns 1,504,959 shares in total.
Roivant Sciences Ltd (ROIV) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.3 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.24) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Roivant Sciences Ltd (ROIV) is currently performing well based on its current performance indicators. A quick ratio of 40.54 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 584.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
The latest stats from [Roivant Sciences Ltd, ROIV] show that its last 5-days average volume of 9.46 million was superior to 6.42 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 88.88%.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 97.71%, which indicates a significant increase from 93.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.57 in the past 14 days, which was higher than the 0.39 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.65, while its 200-day Moving Average is $12.14. Now, the first resistance to watch is $20.07. This is followed by the second major resistance level at $20.26. The third major resistance level sits at $20.64. If the price goes on to break the first support level at $19.50, it is likely to go to the next support level at $19.12. The third support level lies at $18.93 if the price breaches the second support level.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
Market capitalization of the company is 13.57 billion based on 682,882K outstanding shares. Right now, sales total 29,050 K and income totals -171,980 K. The company made 2,170 K in profit during its latest quarter, and -223,360 K in sales during its previous quarter.
